Adaptive Phage Therapeutics (APT) is a clinical-stage company advancing therapies addressing multi-drug resistant infections. Prior antimicrobial therapeutic approaches have been “fixed,” while pathogens continue to evolve resistance to each of those therapeutics, causing those drug products to become rapidly less effective in commercial use as antimicrobial resistance (AMR) increases over time.

Biotechnology

Adaptive Phage Therapeutics

Adaptive Phage Therapeutics' headquarters in Gaithersburg, MD, United States

Rob Casper

Carl R. Merril

Emae Lee-Voritskul, CPA

Zuriel Rivas

Mike Sowers

Dale Eadie

Stephen Johnson

Anantha Makineni, MS PMP

Siblian Boston

Jonathan Leff

Evan Loh

Martin Heidecker

Raymond D. Martz

Jesse Goodman

Directors and Managers

Adaptive Phage Therapeutics

Org chart

Board & advisors

Teams

Directors and Managers

Offices

Similar companies